Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, 131 Princess Street, Manchester, M1 7DN, UK.
Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, 131 Princess Street, Manchester, M1 7DN, UK; René Crevel Consulting Ltd, 3 Woodlands Close, Cople, Bedford, MK44 3UE, UK.
Food Chem Toxicol. 2022 Sep;167:113273. doi: 10.1016/j.fct.2022.113273. Epub 2022 Jul 7.
The susceptibility of a novel food protein to digestion in the pepsin resistance test is widely used to inform the allergenicity risk assessment process. However, it does not model the variation in the intragastric environment found in vivo. Consequently a 96-well plate format in vitro gastric digestion protocol has been developed with a high and low pepsin activity test executed at pH 1.2, 2.5, 5.5 and 6.5. It was used to analyse seven allergens (from milk, egg, peach and peanut) and two non-allergens (cytochrome c and zein). Digestion was monitored using SDS-PAGE and densitometry. In silico predictions were not confirmed experimentally for most of the proteins studied. Proteins were ranked according to half-life and showed susceptibility to digestion was related to the stability of protein structure and protein solubility rather than allergenicity per se. Highly digestible proteins, such as β-casein and Ara h 1, generated abundant resistant fragments Mr > 3.5 kDa in the low pepsin activity test which could be immunologically significant within the context of allergenicity risk assessment for susceptible groups such as infants. The high- and low pepsin activity tests used in this study provided complementary data to support allergenicity risk assessment and used only 10 mg protein.
新型食物蛋白在胃蛋白酶抵抗试验中的消化易感性被广泛用于告知致敏性风险评估过程。然而,它不能模拟体内胃内环境的变化。因此,开发了一种 96 孔板格式的体外胃消化方案,在 pH 值为 1.2、2.5、5.5 和 6.5 时进行高和低胃蛋白酶活性测试。该方案用于分析七种过敏原(来自牛奶、鸡蛋、桃和花生)和两种非过敏原(细胞色素 c 和玉米醇溶蛋白)。使用 SDS-PAGE 和密度计监测消化。大多数研究的蛋白质在计算机预测中未得到实验证实。根据半衰期对蛋白质进行排序,显示消化的易感性与蛋白质结构和蛋白质溶解度的稳定性有关,而与致敏性本身无关。高度可消化的蛋白质,如β-乳球蛋白和 Ara h 1,在低胃蛋白酶活性测试中产生大量大于 3.5 kDa 的抗性片段,这在致敏性风险评估中对于婴儿等易感人群可能具有免疫意义。本研究中使用的高和低胃蛋白酶活性测试提供了互补数据,以支持致敏性风险评估,并且仅使用 10 mg 蛋白质。